This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
de la Monte SD, Moore GW, Hutchins GM. Patterned distribution of metastases from malignant melanoma in humans. Cancer Res 1983; 43: 3427-33. PMID: 6850649dela Monte SDMooreGWHutchinsGMPatterned distribution of metastases from malignant melanoma in humans198343342733PMID: 6850649Search in Google Scholar
Amer MH, Al-Sarraf M, Baker LH, Vaitkevicius VK. Malignant melanoma and central nervous system metastases. Incidence, diagnosis, treatment and survival. Cancer 1978; 42: 660-8. doi:10.1002/1097-0142(197808)42:2<660::AID-CNCR2820420237>3.0.CO;2-EAmerMHAl-SarrafMBakerLHVaitkeviciusVKMalignant melanoma and central nervous system metastases197842660810.1002/1097-0142(197808)42:2<660::AID-CNCR2820420237>3.0.CO;2-EOpen DOISearch in Google Scholar
Zhang D, Wang Z, Shang D, Yu J, Yuan S. Incidence and prognosis of brain metastases in cutaneous melanoma patients: a population-based study. Melanoma Res 2019; 29: 77-84. doi: 10.1097/CMR.0000000000000538ZhangDWangZShangDYuJYuanSIncidence and prognosis of brain metastases in cutaneous melanoma patients: a population-based study201929778410.1097/CMR.0000000000000538Open DOISearch in Google Scholar
Chukwueke U, Batchelor T, Brastianos P. Management of brain metastases in patients with melanoma. J Oncol Practice 2016; 12: 536-42. doi: 10.1200/JOP.2016.011882ChukwuekeUBatchelorTBrastianosPManagement of brain metastases in patients with melanoma2016125364210.1200/JOP.2016.011882Open DOISearch in Google Scholar
Raizer JJ, Hwu WJ, Panageas KS, Wilton A, Baldwin DE, Bailey E, et al. Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features. Neuro Oncol 2008; 10: 199-207. doi: 10.1215/15228517-2007-058RaizerJJHwuWJPanageasKSWiltonABaldwinDEBaileyEet alBrain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features20081019920710.1215/15228517-2007-058Open DOISearch in Google Scholar
Winston K, Walsh J, Fischer E. Results of operative treatment of intracranial metastatic tumors. Cancer 1980; 45: 2639-45. doi: 10.1002/1097-0142(19800515)45:10<2639::AID-CNCR2820451025>3.0.CO;2-OWinstonKWalshJFischerEResults of operative treatment of intracranial metastatic tumors19804526394510.1002/1097-0142(19800515)45:10<2639::AID-CNCR2820451025>3.0.CO;2-OOpen DOISearch in Google Scholar
Pasquali S, Hadjinicolaou AV, Chiarion Sileni V, Rossi CR, Mocellin S. Systemic treatments for metastatic cutaneous melanoma. Cochrane Database Syst Rev 2018; 2: CD011123. doi: 10.1002/14651858.CD011123.pub2PasqualiSHadjinicolaouAVChiarionSileni VRossiCRMocellinSSystemic treatments for metastatic cutaneous melanoma20182CD01112310.1002/14651858.CD011123.pub2Open DOISearch in Google Scholar
Hao C, Tian J, Liu H, Li F, Niu H, Zhu B. Efficacy and safety of anti-PD-1 and anti-PD-1 combined with anti-CTLA-4 immunotherapy to advanced melanoma: a systematic review and meta-analysis of randomized controlled trials. Medicine 2017; 96: e7325. doi: 10.1097/MD.0000000000007325HaoCTianJLiuHLiFNiuHZhuBEfficacy and safety of anti-PD-1 and anti-PD-1 combined with anti-CTLA-4 immunotherapy to advanced melanoma: a systematic review and meta-analysis of randomized controlled trials201796e732510.1097/MD.0000000000007325Open DOISearch in Google Scholar
Dequen P, Lorigan P, Jansen JP, van Baardewijk M, Ouwens MJ, Kotapati S. Systematic review and network meta-analysis of overall survival comparing 3 mg/kg ipilimumab with alternative therapies in the management of pretreated patients with unresectable stage III or IV melanoma. Oncologist 2012; 17: 1376-85. doi: 10.1634/theoncologist.2011-0427DequenPLoriganPJansenJPvanBaardewijk MOuwensMJKotapatiSSystematic review and network meta-analysis of overall survival comparing 3 mg/kg ipilimumab with alternative therapies in the management of pretreated patients with unresectable stage III or IV melanoma20121713768510.1634/theoncologist.2011-0427Open DOISearch in Google Scholar
Rulli E, Legramandi L, Salvati L, Mandala M. The impact of targeted therapies and immunotherapy in melanoma brain metastases: a systematic review and meta-analysis. Cancer 2019; 125: 3776-89. doi: 10.1002/cncr.32375RulliELegramandiLSalvatiLMandalaMThe impact of targeted therapies and immunotherapy in melanoma brain metastases: a systematic review and meta-analysis201912537768910.1002/cncr.32375Open DOISearch in Google Scholar
van Opijnen MP, Dirven L, Coremans IEM, Taphoorn MJB, Kapiteijn EHW. The impact of current treatment modalities on the outcomes of patients with melanoma brain metastases: a systematic review. Int J Cancer 2020; 146: 1479-89. doi: 10.1002/ijc.32696vanOpijnen MPDirvenLCoremansIEMTaphoornMJBKapiteijnEHWThe impact of current treatment modalities on the outcomes of patients with melanoma brain metastases: a systematic review202014614798910.1002/ijc.32696Open DOISearch in Google Scholar
Coit DG, Thompson JA, Albertini MR, Barker C, Carson III WE, Contreras C, et al. Cutaneous melanoma, version 2.2019, NCCN clinical practice guidelines in oncology. Natl Compr Canc Netw 2019; 17: e1. doi: 10.6004/jnccn.2019.0018CoitDGThompsonJAAlbertiniMRBarkerCCarsonIII WEContrerasCet alCutaneous melanoma, version 2.2019, NCCN clinical practice guidelines in oncology201917e110.6004/jnccn.2019.001830959471Open DOISearch in Google Scholar
Long GS, Shivalingam B, Carlino M, Hong, A, Atkinson, V, Kefford, R, et al. Summary of recommendations and practice points: treatment approaches to brain metastases for patients with melanoma. Sydney: Cancer Council Australia; 2019 [updated 2019 Mar 7]; [cited 2021 Jan 28]. Available at: https://wiki.cancer.org.au/australia/Guidelines:Melanoma/Summary_of_treatment_approaches_to_brain_metastasesLongGSShivalingamBCarlinoMHongAAtkinsonVKeffordRetalSydneyCancer Council Australia2019[updated 2019 Mar 7]; [cited 2021 Jan 28]. Available athttps://wiki.cancer.org.au/australia/Guidelines:Melanoma/Summary_of_treatment_approaches_to_brain_metastasesSearch in Google Scholar
Michielin O, Van Akkooi A, Ascierto P, Dummer R, Keilholz U. Cutaneous melanoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2019; 30: 1884-901. doi: 10.1093/annonc/mdz411MichielinOVanAkkooi AAsciertoPDummerRKeilholzUCutaneous melanoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up201930188490110.1093/annonc/mdz41131566661Open DOISearch in Google Scholar
Hong AM, Waldstein C, Shivalingam B, Carlino MS, Atkinson V, Kefford RF, et al. Management of melanoma brain metastases: evidence-based clinical practice guidelines by Cancer Council Australia. Eur J Cancer 2021; 142: 10-7. doi: 10.1016/j.ejca.2020.10.013HongAMWaldsteinCShivalingamBCarlinoMSAtkinsonVKeffordRFet alManagement of melanoma brain metastases: evidence-based clinical practice guidelines by Cancer Council Australia202114210710.1016/j.ejca.2020.10.01333207293Open DOISearch in Google Scholar
Tsao MN, Lloyd NS, Wong RK, Rakovitch E, Chow E, Laperriere N. Radiotherapeutic management of brain metastases: a systematic review and meta-analysis. Cancer Treat Rev 2005; 31: 256-73. doi: 10.1016/j.ctrv.2005.04.007TsaoMNLloydNSWongRKRakovitchEChowELaperriereNRadiotherapeutic management of brain metastases: a systematic review and meta-analysis2005312567310.1016/j.ctrv.2005.04.00715951117Open DOISearch in Google Scholar
Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004; 363: 1665-72. doi: 10.1016/S0140-6736(04)16250-8AndrewsDWScottCBSperdutoPWFlandersAEGasparLESchellMCet alWhole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial200436316657210.1016/S0140-6736(04)16250-815158627Open DOISearch in Google Scholar
Chen JC, Petrovich Z, O’Day S, Morton D, Essner R, Giannotta SL, et al. Stereotactic radiosurgery in the treatment of metastatic disease to the brain. Neurosurgery 2000; 47: 268-81. doi: 10.1097/00006123-200008000-00003ChenJCPetrovichZO’DaySMortonDEssnerRGiannottaSLet alStereotactic radiosurgery in the treatment of metastatic disease to the brain2000472688110.1097/00006123-200008000-0000310942000Open DOISearch in Google Scholar
Brastianos HC, Nguyen P, Sahgal A, Eisenhauer EA, Baetz T, Hanna TP. Association of innovations in radiotherapy and systemic treatments with clinical outcomes in patients with melanoma brain metastasis from 2007 to 2016. JAMA Netw Open 2020; 3: e208204. doi: 10.1001/jamanetworko-pen.2020.8204BrastianosHCNguyenPSahgalAEisenhauerEABaetzTHannaTPAssociation of innovations in radiotherapy and systemic treatments with clinical outcomes in patients with melanoma brain metastasis from 2007 to 201620203e20820410.1001/jamanetworko-pen.2020.8204Open DOISearch in Google Scholar
Barbour AB, Jacobs CD, Williamson H, Floyd SR, Suneja G, Torok JA, et al. Radiation therapy practice patterns for brain metastases in the United States in the stereotactic radiosurgery era. Adv Radiat Oncol 2020; 5: 43-52. doi: 10.1016/j.adro.2019.07.012BarbourABJacobsCDWilliamsonHFloydSRSunejaGTorokJAet alRadiation therapy practice patterns for brain metastases in the United States in the stereotactic radiosurgery era20205435210.1016/j.adro.2019.07.012700494032051889Open DOISearch in Google Scholar
Sandler KA, Shaverdian N, Cook RR, Kishan AU, King CR, Yang I, et al. Treatment trends for patients with brain metastases: does practice reflect the data? Cancer 2017; 123: 2274-82. doi: 10.1002/cncr.30607SandlerKAShaverdianNCookRRKishanAUKingCRYangIet alTreatment trends for patients with brain metastases: does practice reflect the data?201712322748210.1002/cncr.3060728178376Open DOISearch in Google Scholar
Waldstein C, Wang W, Lo S, Shivalingam B, Fogarty GB, Carlino MS, et al. Melanoma brain metastases: the outcome of whole brain radiation therapy in the era of effective systemic therapy. Ther Radiol Oncol 2021; 5: 1-11. doi: 10.21037/tro-21-6WaldsteinCWangWLoSShivalingamBFogartyGBCarlinoMSet alMelanoma brain metastases: the outcome of whole brain radiation therapy in the era of effective systemic therapy2021511110.21037/tro-21-6Open DOISearch in Google Scholar
NCCN. NCCN Guidelines Version 3.2022 Melanoma: Cutaneous US2022. [cited 2022 Mar 15]. Available at: https://www.nccn.org/professionals/physician_gls/pdf/cutaneous_melanoma.pdfAvailable athttps://www.nccn.org/professionals/physician_gls/pdf/cutaneous_melanoma.pdfSearch in Google Scholar
Garbe C, Amaral T, Peris K, Hauschild A, Arenberger P, Bastholt L, et al. European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2019. Eur J Cancer 2020; 126: 159-77. doi: 10.1016/j.ejca.2019.11.015GarbeCAmaralTPerisKHauschildAArenbergerPBastholtLet alEuropean consensus-based interdisciplinary guideline for melanoma20201261597710.1016/j.ejca.2019.11.01531866016Open DOISearch in Google Scholar
Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute. 2011. [cited 2022 Mar 14]. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htmPetersonJWelchVLososMTugwellPOttawaOttawa Hospital Research Institute2011[cited 2022 Mar 14]. Available athttp://www.ohri.ca/programs/clinical_epidemiology/oxford.htmSearch in Google Scholar
Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomsied trials. BMJ 2011; 343: d5928. doi: 10.1136/bmj.d5928HigginsJPAltmanDGGøtzschePCJüniPMoherDOxmanADet alThe Cochrane Collaboration’s tool for assessing risk of bias in randomsied trials2011343d592810.1136/bmj.d5928319624522008217Open DOISearch in Google Scholar
IBM. Statistical Software for the Social Sciences (SPSS) version 25. Armonk, NY: IBM Corp; 2016.Armonk, NYIBM Corp2016Search in Google Scholar
Hauswald H, Bernhardt D, Krug D, Katayama S, Habl G, Lorenzo Bermejo J, et al. Whole-brain helical tomotherapy with integrated boost for brain metastases in patients with malignant melanoma - final results of the BRAIN-RT trial. Cancer Manag Res 2019; 11: 4669-76. doi: 10.2147/CMAR.S204729HauswaldHBernhardtDKrugDKatayamaSHablGLorenzoBermejo Jet alWhole-brain helical tomotherapy with integrated boost for brain metastases in patients with malignant melanoma - final results of the BRAIN-RT trial20191146697610.2147/CMAR.S204729653883531213892Open DOISearch in Google Scholar
Gupta A, Roberts C, Tysoe F, Goff M, Nobes J, Lester J, et al. RADVAN: a randomised phase 2 trial of WBRT plus vandetanib for melanoma brain metastases - results and lessons learnt. Br J Cancer 2016; 115: 1193-200. doi: 10.1038/bjc.2016.318GuptaARobertsCTysoeFGoffMNobesJLesterJet alRADVAN: a randomised phase 2 trial of WBRT plus vandetanib for melanoma brain metastases - results and lessons learnt2016115119320010.1038/bjc.2016.318510489127711083Open DOISearch in Google Scholar
Hong AM, Fogarty GB, Dolven-Jacobsen K, Burmeister BH, Lo SN, Haydu LE, et al. Adjuvant whole-brain radiation therapy compared with observation after local treatment of melanoma brain metastases: a multicenter, randomized phase III trial. J Clin Oncol 2019; 37: 3132-41. doi: 10.1200/JCO.19.01414HongAMFogartyGBDolven-JacobsenKBurmeisterBHLoSNHayduLEet alAdjuvant whole-brain radiation therapy compared with observation after local treatment of melanoma brain metastases: a multicenter, randomized phase III trial20193731324110.1200/JCO.19.0141431553661Open DOISearch in Google Scholar
Partl R, Richtig E, Avian A, Berghold A, Kapp KS. Karnofsky performance status and lactate dehydrogenase predict the benefit of palliative whole-brain irradiation in patients with advanced intra-and extracranial metastases from malignant melanoma. Int J Radiat Oncol Biol Phys 2013; 85: 662-6. doi: 10.1016/j.ijrobp.2012.06.009PartlRRichtigEAvianABergholdAKappKSKarnofsky performance status and lactate dehydrogenase predict the benefit of palliative whole-brain irradiation in patients with advanced intra-and extracranial metastases from malignant melanoma201385662610.1016/j.ijrobp.2012.06.00922901382Open DOISearch in Google Scholar
Samlowski WE, Watson GA, Wang M, Rao G, Klimo Jr P, Boucher K, et al. Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS). Cancer 2007; 109: 1855-62. doi: 10.1002/cncr.22605SamlowskiWEWatsonGAWangMRaoGKlimoJr PBoucherKet alMultimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS)200710918556210.1002/cncr.2260517351953Open DOISearch in Google Scholar
Hauswald H, Dittmar JO, Habermehl D, Rieken S, Sterzing F, Debus J, et al. Efficacy and toxicity of whole brain radiotherapy in patients with multiple cerebral metastases from malignant melanoma. Radiat Oncol 2012; 7: 130. doi: 10.1186/1748-717X-7-130HauswaldHDittmarJOHabermehlDRiekenSSterzingFDebusJet alEfficacy and toxicity of whole brain radiotherapy in patients with multiple cerebral metastases from malignant melanoma2012713010.1186/1748-717X-7-130344438522857154Open DOISearch in Google Scholar
Davies MA, Liu P, McIntyre S, Kim KB, Papadopoulos N, Hwu WJ, et al. Prognostic factors for survival in melanoma patients with brain metastases. Cancer 2011; 117: 1687-96. doi: 10.1002/cncr.25634DaviesMALiuPMcIntyreSKimKBPapadopoulosNHwuWJet alPrognostic factors for survival in melanoma patients with brain metastases201111716879610.1002/cncr.2563420960525Open DOISearch in Google Scholar
Knisely JP, Yu JB, Flanigan J, Sznol M, Kluger HM, Chiang VL. Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival. J Neurosurg 2012; 117: 227-33. doi: 10.3171/2012.5.JNS111929KniselyJPYuJBFlaniganJSznolMKlugerHMChiangVLRadiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival20121172273310.3171/2012.5.JNS111929609893822702482Open DOISearch in Google Scholar
Gieger M, Wu JK, Ling MN, Wazer D, Tsai JS, Engler MJ. Response of intracranial melanoma metastases to stereotactic radiosurgery. Radiat Oncol Investig 1997; 5: 72-80. doi: 10.1002/%28SICI%291520-6823%281997%295:2%3C72::AID-ROI5%3E3.0.CO;2-GGiegerMWuJKLingMNWazerDTsaiJSEnglerMJResponse of intracranial melanoma metastases to stereotactic radiosurgery19975728010.1002/%28SICI%291520-6823%281997%295:2%3C72::AID-ROI5%3E3.0.CO;2-GOpen DOISearch in Google Scholar
Fife K, Colman M, Stevens G, Firth I, Moon D, Shannon K, et al. Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol 2004; 22: 1293-300. doi: 10.1200/JCO.2004.08.140FifeKColmanMStevensGFirthIMoonDShannonKet alDeterminants of outcome in melanoma patients with cerebral metastases200422129330010.1200/JCO.2004.08.140Open DOISearch in Google Scholar
Stevens G, Firth I, Coates A. Cerebral metastases from malignant melanoma. Radiother Oncol 1992; 23: 185-91. doi: 10.1016/0167-8140(92)90329-SStevensGFirthICoatesACerebral metastases from malignant melanoma1992231859110.1016/0167-8140(92)90329-SOpen DOISearch in Google Scholar
Szyszka-Charewicz B. The effectiveness of brain metastases radiotherapy in patients with melanoma. Nowotwory 2016; 66: 367-74. doi: 10.5603/NJO.2016.0066Szyszka-CharewiczB.The effectiveness of brain metastases radiotherapy in patients with melanoma2016663677410.5603/NJO.2016.0066Open DOISearch in Google Scholar
Isokangas OP, Muhonen T, Kajanti M, Pyrhonen S. Radiation therapy of intracranial malignant melanoma. Radiother Oncol 1996; 38: 139-44. doi: 10.1016/0167-8140(95)01691-0IsokangasOPMuhonenTKajantiMPyrhonenSRadiation therapy of intracranial malignant melanoma1996381394410.1016/0167-8140(95)01691-0Open DOISearch in Google Scholar
Silk AW, Bassetti MF, West BT, Tsien CI, Lao CD. Ipilimumab and radiation therapy for melanoma brain metastases. Cancer Med 2013; 2: 899-906. doi: 10.1002/cam4.140SilkAWBassettiMFWestBTTsienCILaoCDIpilimumab and radiation therapy for melanoma brain metastases2013289990610.1002/cam4.140Open DOISearch in Google Scholar
Phillips WJ, Lo B, Ong M, Smith T, Song X. Clinical outcomes in patients with melanoma brain metastases at a tertiary cancer center. J Clin Oncol 2019; 37(Suppl 15): e13586. [abstract]. doi: 10.1200/JCO.2019.37.15-suppl.e13586PhillipsWJLoBOngMSmithTSongXClinical outcomes in patients with melanoma brain metastases at a tertiary cancer center201937Suppl 15e13586[abstract]10.1200/JCO.2019.37.15-suppl.e13586Open DOISearch in Google Scholar
Byrne TN, Cascino TL, Posner JB. Brain metastasis from melanoma. J Neurooncol 1983; 1: 313-7. doi: 10.1007/BF00165714ByrneTNCascinoTLPosnerJBBrain metastasis from melanoma19831313710.1007/BF00165714Open DOISearch in Google Scholar
Rate WR, Solin LJ, Turrisi AT. Palliative radiotherapy for metastatic malignant melanoma: brain metastases, bone metastases, and spinal cord compression. Int J Radiat Oncol Biol Phys 1988; 15: 859-64. doi: 10.1016/0360-3016(88)90118-6RateWRSolinLJTurrisiATPalliative radiotherapy for metastatic malignant melanoma: brain metastases, bone metastases, and spinal cord compression1988158596410.1016/0360-3016(88)90118-6Open DOISearch in Google Scholar
Cooney RM WB, Altman DG, Abreu MT, Travis SPL. Outcome measurement in clinical trials for ulcerative colitis: toward standardisation. Trials 2007; 8: 17. doi: 10.1186/1745-6215-8-17CooneyRM WBAltmanDGAbreuMTTravisSPLOutcome measurement in clinical trials for ulcerative colitis: toward standardisation200781710.1186/1745-6215-8-17Open DOISearch in Google Scholar
Mak KS, Van Bommel AC, Stowell C, Abrahm JL, Baker M, Baldotto CS, et al. Defining a standard set of patient-centred outcomes for lung cancer. Eur Respir J 2016; 48: 852-60. doi: 10.1183/13993003.02049-2015MakKSVanBommel ACStowellCAbrahmJLBakerMBaldottoCSet alDefining a standard set of patient-centred outcomes for lung cancer2016488526010.1183/13993003.02049-2015500722127390281Open DOISearch in Google Scholar
Tugwell P, Boers M, Brooks P, Simon LS, Strand V, Idzerda L. OMERACT: an international initiative to improve outcome measurement in rheumatology. Trials 2007; 8: 38. doi: 10.1186/1745-6215-8-38TugwellPBoersMBrooksPSimonLSStrandVIdzerdaLOMERACT: an international initiative to improve outcome measurement in rheumatology200783810.1186/1745-6215-8-38216926018039364Open DOISearch in Google Scholar
Tong A, Manns B, Wang AYM, Hemmelgarn B, Wheeler DC, Gill J, et al. Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop. Kidney Int 2018; 94: 1053-68. doi: 10.1016/j.kint.2018.08.018TongAMannsBWangAYMHemmelgarnBWheelerDCGillJet alImplementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop20189410536810.1016/j.kint.2018.08.018662075530360959Open DOISearch in Google Scholar
Tunis SR, Maxwell LJ, Graham ID, Shea BJ, Beaton DE, Bingham CO, et al. Engaging stakeholders and promoting uptake of OMERACT core outcome instrument sets. J Rheumatol 2017; 44: 1551-9. doi: 10.3899/jrheum.161273TunisSRMaxwellLJGrahamIDSheaBJBeatonDEBinghamCOet alEngaging stakeholders and promoting uptake of OMERACT core outcome instrument sets2017441551910.3899/jrheum.16127328765256Open DOISearch in Google Scholar
Carella RJ, Gelber R, Hendrickson F, Berry HC, Cooper JS. Value of radiation therapy in the management of patients with cerebral metastases from malignant melanoma: radiation therapy oncology group brain metastases study I and II. Cancer 1980; 45: 679-83. doi: 10.1002/1097-0142(19800215)45:4<679::AID-CNCR2820450410>3.0.CO;2-JCarellaRJGelberRHendricksonFBerryHCCooperJSValue of radiation therapy in the management of patients with cerebral metastases from malignant melanoma: radiation therapy oncology group brain metastases study I and II1980456798310.1002/1097-0142(19800215)45:4<679::AID-CNCR2820450410>3.0.CO;2-JOpen DOISearch in Google Scholar
Katz HR. The relative effectiveness of radiation therapy, corticosteroids, and surgery in the management of melanoma metastatic to the central nervous system. Int J Radiat Oncol Biol Phys 1981; 7: 897-906. doi: 10.1016/0360-3016(81)90006-7KatzHRThe relative effectiveness of radiation therapy, corticosteroids, and surgery in the management of melanoma metastatic to the central nervous system1981789790610.1016/0360-3016(81)90006-7Open DOISearch in Google Scholar
Vlock DR, Kirkwood JM, Leutzinger C, Kapp DS, Fischer JJ. High-dose fraction radiation therapy for intracranial metastases of malignant melanoma: a comparison with low-dose fraction therapy. Cancer 1982; 49: 2289-94. doi: 10.1002/1097-0142(19820601)49:11<2289::AID-CNCR2820491115>3.0.CO;2-8VlockDRKirkwoodJMLeutzingerCKappDSFischerJJHigh-dose fraction radiation therapy for intracranial metastases of malignant melanoma: a comparison with low-dose fraction therapy19824922899410.1002/1097-0142(19820601)49:11<2289::AID-CNCR2820491115>3.0.CO;2-8Open DOISearch in Google Scholar
Stridsklev IC, Hagen S, Klepp O. Radiation therapy for brain metastases from malignant melanoma. Acta Radiol Oncol 1984; 23: 231-5. doi: 10.3109/02841868409136017StridsklevICHagenSKleppORadiation therapy for brain metastases from malignant melanoma198423231510.3109/02841868409136017Open DOISearch in Google Scholar
Choi KN, Withers HR, Rotman M. Metastatic melanoma in brain. Rapid treatment or large dose fractions. Cancer 1985; 56: 10-5. doi: 10.1002/1097-0142(19850701)56:1<10::AID-CNCR2820560103>3.0.CO;2-GChoiKNWithersHRRotmanMMetastatic melanoma in brain19855610510.1002/1097-0142(19850701)56:1<10::AID-CNCR2820560103>3.0.CO;2-GOpen DOISearch in Google Scholar
Choi KN, Withers HR, Rotman M. Intracranial metastases from melanoma. Clinical features and treatment by accelerated fractionation. Cancer 1985; 56: 1-9. doi: 10.1002/1097-0142%2819850701%2956:1%3C1::AID-CNCR2820560102%3E3.0.CO;2-XChoiKNWithersHRRotmanMIntracranial metastases from melanoma1985561910.1002/1097-0142%2819850701%2956:1%3C1::AID-CNCR2820560102%3E3.0.CO;2-XOpen DOISearch in Google Scholar
Ziegler JC, Cooper JS. Brain metastases from malignant melanoma: conventional vs. high-dose-per-fraction radiotherapy. Int J Radiat Oncol Biol Phys 1986; 12: 1839-42. doi: 10.1016/0360-3016(86)90327-5ZieglerJCCooperJSBrain metastases from malignant melanoma: conventional vs19861218394210.1016/0360-3016(86)90327-53759534Open DOISearch in Google Scholar
Hagen NA, Cirrincione C, Thaler HT, DeAngelis LM. The role of radiation therapy following resection of single brain metastasis from melanoma. Neurology 1990; 40: 158-60. doi: 10.1212/WNL.40.1.158HagenNACirrincioneCThalerHTDeAngelisLMThe role of radiation therapy following resection of single brain metastasis from melanoma1990401586010.1212/WNL.40.1.158Open DOISearch in Google Scholar
Somaza S, Kondziolka D, Lunsford LD, Kirkwood JM, Flickinger JC. Stereotactic radiosurgery for cerebral metastatic melanoma. J Neurosurg 1993; 79: 661-6. doi: 10.3171/jns.1993.79.5.0661SomazaSKondziolkaDLunsfordLDKirkwoodJMFlickingerJCStereotactic radiosurgery for cerebral metastatic melanoma199379661610.3171/jns.1993.79.5.06618410244Open DOISearch in Google Scholar
Willner J, Bohndorf W. [CNS metastases in malignant melanomas]. [German]. Strahlenther Onkol 1995; 171: 165-73. PMID: 7709333WillnerJBohndorfW[CNS metastases in malignant melanomas]199517116573PMID: 7709333Search in Google Scholar
Skibber JM, Soong SJ, Austin L, Balch CM, Sawaya RE. Cranial irradiation after surgical excision of brain metastases in melanoma patients. Ann Surg Oncol 1996; 3: 118-23. doi: 10.1007/BF02305789SkibberJMSoongSJAustinLBalchCMSawayaRECranial irradiation after surgical excision of brain metastases in melanoma patients199631182310.1007/BF023057898646510Open DOISearch in Google Scholar
Gupta G, Robertson AG, MacKie RM. Cerebral metastases of cutaneous melanoma. Br J Cancer 1997; 76: 256-9. doi: 10.1038/bjc.1997.371GuptaGRobertsonAGMacKieRMCerebral metastases of cutaneous melanoma199776256910.1038/bjc.1997.37122239309231928Open DOISearch in Google Scholar
Grob JJ, Regis J, Laurans R, Delaunay M, Wolkenstein P, Paul K, et al. Radiosurgery without whole brain radiotherapy in melanoma brain metastases. Eur J Cancer 1998; 34: 1187-92. doi: 10.1016/S0959-8049%2898%2900026-4GrobJJRegisJLauransRDelaunayMWolkensteinPPaulKet alRadiosurgery without whole brain radiotherapy in melanoma brain metastases19983411879210.1016/S0959-8049%2898%2900026-4Open DOISearch in Google Scholar
Sampson JH, Carter JH, Friedman AH, Seigler HF. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg 1998; 88: 11-20. doi: 10.3171/jns.1998.88.1.0011SampsonJHCarterJHFriedmanAHSeiglerHFDemographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma199888112010.3171/jns.1998.88.1.00119420067Open DOISearch in Google Scholar
Seung SK, Sneed PK, McDermott MW, Shu HK, Leong SP, Chang S, et al. Gamma knife radiosurgery for malignant melanoma brain metastases. Cancer J Sci Am 1998; 4: 103-9. PMID: 9532412SeungSKSneedPKMcDermottMWShuHKLeongSPChangSet alGamma knife radiosurgery for malignant melanoma brain metastases199841039PMID: 9532412Search in Google Scholar
Lavine SD, Petrovich Z, Cohen-Gadol AA, Masri LS, Morton DL, O’Day SJ, et al. Gamma knife radiosurgery for metastatic melanoma: an analysis of survival, outcome, and complications. Neurosurgery 1999; 44: 59-66. doi: 10.1097/00006123-199901000-00031LavineSDPetrovichZCohen-GadolAAMasriLSMortonDLO’DaySJet alGamma knife radiosurgery for metastatic melanoma: an analysis of survival, outcome, and complications199944596610.1097/00006123-199901000-000319894964Open DOISearch in Google Scholar
Konstadoulakis M, Messaris E, Zografos G, Androulakis G. Prognostic factors in malignant melanoma patients with solitary or multiple brain metastases: is there a role for surgery? J Neurosurg Sci 2000; 44: 211-8. PMID: 11327290KonstadoulakisMMessarisEZografosGAndroulakisGPrognostic factors in malignant melanoma patients with solitary or multiple brain metastases: is there a role for surgery?2000442118PMID: 11327290Search in Google Scholar
Ellerhorst J, Strom E, Nardone E, McCutcheon I. Whole brain irradiation for patients with metastatic melanoma: a review of 87 cases. Int J Radiat Oncol Biol Phys 2001; 49: 93-7. doi: 10.1016/S0360-3016(00)01355-9EllerhorstJStromENardoneEMcCutcheonIWhole brain irradiation for patients with metastatic melanoma: a review of 87 cases20014993710.1016/S0360-3016(00)01355-911163501Open DOISearch in Google Scholar
Buchsbaum JC, Suh JH, Lee SY, Chidel MA, Greskovich JF, Barnett GH. Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: a retrospective study. Cancer 2002; 94: 2265-72. doi: 10.1002/cncr.10426BuchsbaumJCSuhJHLeeSYChidelMAGreskovichJFBarnettGHSurvival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: a retrospective study20029422657210.1002/cncr.1042612001126Open DOISearch in Google Scholar
Gonzalez-Martinez J, Hernandez L, Zamorano L, Sloan A, Levin K, Lo S, et al. Gamma knife radiosurgery for intracranial metastatic melanoma: a 6-year experience. J Neurosurg 2002; 97(Suppl. 5): 494-8. doi: 10.3171/jns.2002.97.supplement_5.0494Gonzalez-MartinezJHernandezLZamoranoLSloanALevinKLoSet alGamma knife radiosurgery for intracranial metastatic melanoma: a 6-year experience200297Suppl. 5494810.3171/jns.2002.97.supplement_5.0494Open DOISearch in Google Scholar
Mingione V, Oliveira M, Prasad D, Steiner M, Steiner L. Gamma surgery for melanoma metastases in the brain. J Neurosurg 2002; 96: 544-51. doi: 10.3171/jns.2002.96.3.0544MingioneVOliveiraMPrasadDSteinerMSteinerLGamma surgery for melanoma metastases in the brain2002965445110.3171/jns.2002.96.3.054411883840Open DOISearch in Google Scholar
Noel G, Simon JM, Valery CA, Cornu P, Boisserie G, Ledu D, et al. Linac radiosurgery for brain metastasis of melanoma. Stereotact Funct Neurosurg 2002; 79: 245-55. doi: 10.1159/000070838NoelGSimonJMValeryCACornuPBoisserieGLeduDet alLinac radiosurgery for brain metastasis of melanoma2002792455510.1159/00007083812890983Open DOISearch in Google Scholar
Yu C, Chen JCT, Apuzzo MLJ, O’Day S, Giannotta SL, Weber JS, et al. Metastatic melanoma to the brain: prognostic factors after gamma knife radiosurgery. Int J Radiat Oncol Biol Phys 2002; 52: 1277-87. doi: 10.1016/S0360-3016%2801%2902772-9YuCChenJCTApuzzoMLJO’DaySGiannottaSLWeberJSet alMetastatic melanoma to the brain: prognostic factors after gamma knife radiosurgery20025212778710.1016/S0360-3016%2801%2902772-9Open DOISearch in Google Scholar
Zacest AC, Besser M, Stevens G, Thompson JF, McCarthy WH, Culjak G. Surgical management of cerebral metastases from melanoma: outcome in 147 patients treated at a single institution over two decades. J Neurosurg 2002; 96: 552-8. doi: 10.3171/jns.2002.96.3.0552ZacestACBesserMStevensGThompsonJFMcCarthyWHCuljakGSurgical management of cerebral metastases from melanoma: outcome in 147 patients treated at a single institution over two decades200296552810.3171/jns.2002.96.3.055211883841Open DOISearch in Google Scholar
Harrison BE, Johnson JL, Clough RW, Halperin EC. Selection of patients with melanoma brain metastases for aggressive treatment. Am J Clin Oncol 2003; 26: 354-7. doi: 10.1097/00000421-200308000-00009HarrisonBEJohnsonJLCloughRWHalperinECSelection of patients with melanoma brain metastases for aggressive treatment200326354710.1097/00000421-200308000-00009Open DOISearch in Google Scholar
Conill C, Fernandez-Ibiza J, Malvehy J, Puig S, Sanchez M, Castel T. Temozolomide in patients with melanoma brain metastases treated with whole brain irradiation. Med Clin (Barc) 2004; 122: 413-5. doi: 10.1016/s0025-7753(04)74256-6ConillCFernandez-IbizaJMalvehyJPuigSSanchezMCastelTTemozolomide in patients with melanoma brain metastases treated with whole brain irradiation2004122413510.1016/s0025-7753(04)74256-615066248Open DOISearch in Google Scholar
Meier S, Baumert BG, Maier T, Wellis G, Burg G, Seifert B, et al. Survival and prognostic factors in patients with brain metastases from malignant melanoma. Onkologie 2004; 27: 145-9. doi: 10.1159/000076903MeierSBaumertBGMaierTWellisGBurgGSeifertBet alSurvival and prognostic factors in patients with brain metastases from malignant melanoma200427145910.1159/00007690315138346Open DOISearch in Google Scholar
Morris SL, Low SH, A’Hern RP, Eisen TG, Gore ME, Nutting CM, et al. A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanoma. Br J Cancer 2004; 91: 829-33. doi: 10.1038/sj.bjc.6602018MorrisSLLowSHA’HernRPEisenTGGoreMENuttingCMet alA prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanoma2004918293310.1038/sj.bjc.6602018240988115305201Open DOISearch in Google Scholar
Radbill AE, Fiveash JF, Falkenberg ET, Guthrie BL, Young PE, Meleth S, et al. Initial treatment of melanoma brain metastases using gamma knife radiosurgery: an evaluation of efficacy and toxicity. Cancer 2004; 101: 825-33. doi: 10.1002/cncr.20447RadbillAEFiveashJFFalkenbergETGuthrieBLYoungPEMelethSet alInitial treatment of melanoma brain metastases using gamma knife radiosurgery: an evaluation of efficacy and toxicity20041018253310.1002/cncr.2044715305416Open DOISearch in Google Scholar
Selek U, Chang EL, Hassenbusch SJ, 3rd, Shiu AS, Lang FF, Allen P, et al. Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases. Int J Radiat Oncol Biol Phys 2004; 59: 1097-106. doi: 10.1016/j.ijrobp.2003.12.037SelekUChangELHassenbuschSJ3rdShiuASLangFFAllenPet alStereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases200459109710610.1016/j.ijrobp.2003.12.03715234044Open DOISearch in Google Scholar
Stone A, Cooper J, Koenig KL, Golfinos JG, Oratz R. A comparison of survival rates for treatment of melanoma metastatic to the brain. Cancer Invest 2004; 22: 492-7. doi: 10.1081/CNV-200026387StoneACooperJKoenigKLGolfinosJGOratzRA comparison of survival rates for treatment of melanoma metastatic to the brain200422492710.1081/CNV-20002638715565805Open DOISearch in Google Scholar
Koc M, McGregor J, Grecula J, Bauer CJ, Gupta N, Gahbauer RA. Gamma Knife radiosurgery for intracranial metastatic melanoma: an analysis of survival and prognostic factors. J Neurooncol 2005; 71: 307-13. doi: 10.1007/s11060-004-2027-1KocMMcGregorJGreculaJBauerCJGuptaNGahbauerRAGamma Knife radiosurgery for intracranial metastatic melanoma: an analysis of survival and prognostic factors2005713071310.1007/s11060-004-2027-115735922Open DOISearch in Google Scholar
Panagiotou IE, Brountzos EN, Kelekis DA, Papathanasiou MA, Bafaloukos DI. Cerebral metastases of malignant melanoma: contemporary treatment modalities and survival outcome. Neoplasma 2005; 52: 150-8. PMID: 15800714PanagiotouIEBrountzosENKelekisDAPapathanasiouMABafaloukosDICerebral metastases of malignant melanoma: contemporary treatment modalities and survival outcome2005521508PMID: 15800714Search in Google Scholar
Rhomberg W, Eiter H, Boehler F, Saely C, Strohal R. Combined razoxane and radiotherapy for melanoma brain metastases. a retrospective analysis. J Neurooncol 2005; 74: 295-9. doi: 10.1007/s11060-004-7557-zRhombergWEiterHBoehlerFSaelyCStrohalRCombined razoxane and radiotherapy for melanoma brain metastases200574295910.1007/s11060-004-7557-z16086112Open DOISearch in Google Scholar
Christopoulou A, Retsas S, Kingsley D, Paddick I, Lindquist C. Integration of gamma knife surgery in the management of cerebral metastases from melanoma. Melanoma Res 2006; 16: 51-7. doi: 10.1097/01.cmr.0000198451.26827.b2ChristopoulouARetsasSKingsleyDPaddickILindquistCIntegration of gamma knife surgery in the management of cerebral metastases from melanoma20061651710.1097/01.cmr.0000198451.26827.b216432456Open DOISearch in Google Scholar
Gaudy-Marqueste C, Regis JM, Muracciole X, Laurans R, Richard MA, Bonerandi JJ, et al. Gamma-Knife radiosurgery in the management of melanoma patients with brain metastases: a series of 106 patients without whole-brain radiotherapy. Int J Radiat Oncol Biol Phys 2006; 65: 809-16. doi: 10.1016/j.ijrobp.2006.01.024Gaudy-MarquesteCRegisJMMuraccioleXLauransRRichardMABonerandiJJet alGamma-Knife radiosurgery in the management of melanoma patients with brain metastases: a series of 106 patients without whole-brain radiotherapy2006658091610.1016/j.ijrobp.2006.01.02416682138Open DOISearch in Google Scholar
Conill C, Berenguer J, Vargas M, Lopez-Soriano A, Valduvieco I, Marruecos J, et al. Incidence of radiation-induced leukoencephalopathy after whole brain radiotherapy in patients with brain metastases. Clin Transl Oncol 2007; 9: 590-5. doi: 10.1007/s12094-007-0108-2ConillCBerenguerJVargasMLopez-SorianoAValduviecoIMarruecosJet alIncidence of radiation-induced leukoencephalopathy after whole brain radiotherapy in patients with brain metastases20079590510.1007/s12094-007-0108-217921107Open DOISearch in Google Scholar
Mathieu D, Kondziolka D, Cooper PB, Flickinger JC, Niranjan A, Agarwala S, et al. Gamma knife radiosurgery in the management of malignant melanoma brain metastases. Neurosurgery 2007; 60: 471-81. doi: 10.1227/01.NEU.0000255342.10780.52MathieuDKondziolkaDCooperPBFlickingerJCNiranjanAAgarwalaSet alGamma knife radiosurgery in the management of malignant melanoma brain metastases2007604718110.1227/01.NEU.0000255342.10780.5217327791Open DOISearch in Google Scholar
Redmond AJ, Diluna ML, Hebert R, Moliterno JA, Desai R, Knisely JP, et al. Gamma Knife surgery for the treatment of melanoma metastases: the effect of intratumoral hemorrhage on survival. J Neurosurg 2008; 109 (Suppl): 99-105. doi: 10.3171/JNS/2008/109/12/S16RedmondAJDilunaMLHebertRMoliternoJADesaiRKniselyJPet alGamma Knife surgery for the treatment of melanoma metastases: the effect of intratumoral hemorrhage on survival2008109Suppl9910510.3171/JNS/2008/109/12/S1619123895Open DOISearch in Google Scholar
Carrubba CJ, Vitaz TW. Factors affecting the outcome after treatment for metastatic melanoma to the brain. Surg Neurol 2009; 72: 707-11. doi: 10.1016/j.surneu.2009.03.005CarrubbaCJVitazTWFactors affecting the outcome after treatment for metastatic melanoma to the brain2009727071110.1016/j.surneu.2009.03.00519604550Open DOISearch in Google Scholar
Ahmad S, Ricco A, Brown R, Hanlon A, Yang J, Feng J, et al. Single institutional experience of stereotactic radiosurgery alone for first brain metastatic event and salvage of second brain metastatic event in a community setting with review of the literature. Front Oncol 2017; 7: 32. doi: 10.3389/fonc.2017.00032AhmadSRiccoABrownRHanlonAYangJFengJet alSingle institutional experience of stereotactic radiosurgery alone for first brain metastatic event and salvage of second brain metastatic event in a community setting with review of the literature201773210.3389/fonc.2017.00032534302128337424Open DOISearch in Google Scholar
Rades D, Heisterkamp C, Huttenlocher S, Bohlen G, Dunst J, Haatanen T, et al. Dose escalation of whole-brain radiotherapy for brain metastases from melanoma. Int J Radiat Oncol Biol Phys 2010; 77: 537-41. doi: 10.1016/j.ijrobp.2009.05.001RadesDHeisterkampCHuttenlocherSBohlenGDunstJHaatanenTet alDose escalation of whole-brain radiotherapy for brain metastases from melanoma2010775374110.1016/j.ijrobp.2009.05.00119733017Open DOISearch in Google Scholar
Schild SE, Behl D, Markovic SN, Brown PD, Sande JR, Deming RL, et al. Brain metastases from melanoma: is there a role for concurrent temozolomide in addition to whole brain radiation therapy? Am J Clin Oncol 2010; 33: 633-6. doi: 10.1097/COC.0b013e3181c4c54bSchildSEBehlDMarkovicSNBrownPDSandeJRDemingRLet alBrain metastases from melanoma: is there a role for concurrent temozolomide in addition to whole brain radiation therapy?201033633610.1097/COC.0b013e3181c4c54b569055520042969Open DOISearch in Google Scholar
Staudt M, Lasithiotakis K, Leiter U, Meier F, Eigentler T, Bamberg M, et al. Determinants of survival in patients with brain metastases from cutaneous melanoma. Br J Cancer 2010; 102: 1213-8. doi: 10.1038/sj.bjc.6605622StaudtMLasithiotakisKLeiterUMeierFEigentlerTBambergMet alDeterminants of survival in patients with brain metastases from cutaneous melanoma20101021213810.1038/sj.bjc.6605622285600220372154Open DOISearch in Google Scholar
Eigentler TK, Figl A, Krex D, Mohr P, Mauch C, Rass K, et al. Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma. Cancer 2011; 117: 1697-703. doi: 10.1002/cncr.25631EigentlerTKFiglAKrexDMohrPMauchCRassKet alNumber of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma2011117169770310.1002/cncr.2563121472716Open DOISearch in Google Scholar
Liew DN, Kano H, Kondziolka D, Mathieu D, Niranjan A, Flickinger JC, et al. Outcome predictors of gamma knife surgery for melanoma brain metastases. Clinical article. J Neurosurg 2011; 114: 769-79. doi: 10.3171/2010.5.JNS1014LiewDNKanoHKondziolkaDMathieuDNiranjanAFlickingerJCet alOutcome predictors of gamma knife surgery for melanoma brain metastases20111147697910.3171/2010.5.JNS101420524829Open DOISearch in Google Scholar
Skeie BS, Skeie GO, Enger PO, Ganz JC, Heggdal JI, Ystevik B, et al. Gamma knife surgery in brain melanomas: absence of extracranial metastases and tumor volume strongest indicators of prolonged survival. World Neurosurg 2011; 75: 684-91; discussion 598-603. doi: 10.1016/j.wneu.2010.12.054SkeieBSSkeieGOEngerPOGanzJCHeggdalJIYstevikBet alGamma knife surgery in brain melanomas: absence of extracranial metastases and tumor volume strongest indicators of prolonged survival20117568491discussion 598-60310.1016/j.wneu.2010.12.05421704936Open DOISearch in Google Scholar
Zakrzewski J, Geraghty LN, Rose AE, Christos PJ, Mazumdar M, Polsky D, et al. Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survival. Cancer 2011; 117: 1711-20. doi: 10.1002/cncr.25643ZakrzewskiJGeraghtyLNRoseAEChristosPJMazumdarMPolskyDet alClinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survival201111717112010.1002/cncr.25643311702521472718Open DOISearch in Google Scholar
Bernard ME, Wegner RE, Reineman K, Heron DE, Kirkwood J, Burton SA, et al. Linear accelerator based stereotactic radiosurgery for melanoma brain metastases. J Cancer Res Ther 2012; 8: 215-21. doi: 10.4103/0973-1482.98973BernardMEWegnerREReinemanKHeronDEKirkwoodJBurtonSAet alLinear accelerator based stereotactic radiosurgery for melanoma brain metastases201282152110.4103/0973-1482.9897322842364Open DOISearch in Google Scholar
Koay EJ, Bucheit AD, Jakob JA, Hyun ED, Settle SH, Brown PD, et al. Correlation of BRAF and NRAS mutation status with tumor characteristics and treatment outcomes in melanoma patients with brain metastasis. [abstract]. J Clin Oncol 2012; 30 (15 Suppl 1). doi: 10.1200/jco.2012.30.15_suppl.8584KoayEJBucheitADJakobJAHyunEDSettleSHBrownPDet alCorrelation of BRAF and NRAS mutation status with tumor characteristics and treatment outcomes in melanoma patients with brain metastasis. [abstract]201230(15 Suppl 1)10.1200/jco.2012.30.15_suppl.8584Open DOISearch in Google Scholar
Lo SS, Radawski JD, Nelson A, Clarke JW, McGregor JM, Mayr NA, et al. Stereotactic radiosurgery with or without whole brain radiotherapy for patients with one to three melanoma brain metastases. J Radiat Oncol 2012; 1: 73-9. doi: 10.1007/s13566-012-0006-2LoSSRadawskiJDNelsonAClarkeJWMcGregorJMMayrNAet alStereotactic radiosurgery with or without whole brain radiotherapy for patients with one to three melanoma brain metastases2012173910.1007/s13566-012-0006-2Open DOISearch in Google Scholar
Salvati M, Frati A, D’Elia A, Pescatori L, Piccirilli M, Pietrantonio A, et al. Single brain metastases from melanoma: remarks on a series of 84 patients. Neurosurg Rev 2012; 35: 211-8. doi: 10.1007/s10143-011-0348-zSalvatiMFratiAD’EliaAPescatoriLPiccirilliMPietrantonioAet alSingle brain metastases from melanoma: remarks on a series of 84 patients201235211810.1007/s10143-011-0348-z21915621Open DOISearch in Google Scholar
Mathew M, Tam M, Ott PA, Pavlick AC, Rush SC, Donahue BR, et al. Ipilimumab in melanoma with limited brain metastases treated with stereotactic radiosurgery. Melanoma Res 2013; 23: 191-5. doi: 10.1097/CMR.0b013e32835f3d90MathewMTamMOttPAPavlickACRushSCDonahueBRet alIpilimumab in melanoma with limited brain metastases treated with stereotactic radiosurgery201323191510.1097/CMR.0b013e32835f3d9023462208Open DOISearch in Google Scholar
Miller D, Zappala V, El Hindy N, Livingstone E, Schadendorf D, Sure U, et al. Intracerebral metastases of malignant melanoma and their recurrences--a clinical analysis. Clin Neurol Neurosurg 2013; 115: 1721-8. doi: 10.1016/j.clineuro.2013.03.019MillerDZappalaVElHindy NLivingstoneESchadendorfDSureUet alIntracerebral metastases of malignant melanoma and their recurrences--a clinical analysis20131151721810.1016/j.clineuro.2013.03.01923643143Open DOISearch in Google Scholar
Zukauskaite R, Schmidt H, Asmussen JT, Hansen O, Bastholt L. Asymptomatic brain metastases in patients with cutaneous metastatic malignant melanoma. Melanoma Res 2013; 23: 21-6. doi: 10.1097/CMR.0b013e32835ae915ZukauskaiteRSchmidtHAsmussenJTHansenOBastholtLAsymptomatic brain metastases in patients with cutaneous metastatic malignant melanoma20132321610.1097/CMR.0b013e32835ae91523117880Open DOISearch in Google Scholar
Dyer MA, Arvold ND, Chen YH, Pinnell NE, Mitin T, Lee EQ, et al. The role of whole brain radiation therapy in the management of melanoma brain metastases. Radiat Oncol 2014; 9: 143. doi: 10.1186/1748-717X-9-143DyerMAArvoldNDChenYHPinnellNEMitinTLeeEQet alThe role of whole brain radiation therapy in the management of melanoma brain metastases2014914310.1186/1748-717X-9-143413223024954062Open DOISearch in Google Scholar
Marcus DM, Lowe M, Khan MK, Lawson DH, Crocker IR, Shelton JW, et al. Prognostic factors for overall survival after radiosurgery for brain metastases from melanoma. Am J Clin Oncol 2014; 37: 580-4. doi: 10.1097/COC.0b013e318280d7beMarcusDMLoweMKhanMKLawsonDHCrockerIRSheltonJWet alPrognostic factors for overall survival after radiosurgery for brain metastases from melanoma201437580410.1097/COC.0b013e318280d7be23428955Open DOISearch in Google Scholar
Neal MT, Chan MD, Lucas Jr JT, Loganathan A, Dillingham C, Pan E, et al. Predictors of survival, neurologic death, local failure, and distant failure after gamma knife radiosurgery for melanoma brain metastases. World Neurosurg 2014; 82: 1250-5. doi: 10.1016/j.wneu.2013.02.025NealMTChanMDLucasJr JTLoganathanADillinghamCPanEet alPredictors of survival, neurologic death, local failure, and distant failure after gamma knife radiosurgery for melanoma brain metastases2014821250510.1016/j.wneu.2013.02.02523402867Open DOISearch in Google Scholar
Rades D, Hornung D, Blanck O, Martens K, Khoa MT, Trang NT, et al. Stereotactic radiosurgery for newly diagnosed brain metastases: comparison of three dose levels. Strahlenther Onkol 2014; 190: 786-91. doi: 10.1007/s00066-014-0625-1RadesDHornungDBlanckOMartensKKhoaMTTrangNTet alStereotactic radiosurgery for newly diagnosed brain metastases: comparison of three dose levels20141907869110.1007/s00066-014-0625-124663288Open DOISearch in Google Scholar
Vecchio S, Spagnolo F, Merlo DF, Signori A, Acquati M, Pronzato P, et al. The treatment of melanoma brain metastases before the advent of targeted therapies: associations between therapeutic choice, clinical symptoms and outcome with survival. Melanoma Res 2014; 24: 61-7. doi: 10.1097/CMR.0000000000000029VecchioSSpagnoloFMerloDFSignoriAAcquatiMPronzatoPet alThe treatment of melanoma brain metastases before the advent of targeted therapies: associations between therapeutic choice, clinical symptoms and outcome with survival20142461710.1097/CMR.000000000000002924121190Open DOISearch in Google Scholar
Christ SM, Mahadevan A, Floyd SR, Lam FC, Chen CC, Wong ET, et al. Stereotactic radiosurgery for brain metastases from malignant melanoma. Surg Neurol Int 2015; 6(Suppl 12): S355. doi: 10.4103/2152-7806.163315ChristSMMahadevanAFloydSRLamFCChenCCWongETet alStereotactic radiosurgery for brain metastases from malignant melanoma20156Suppl 12S35510.4103/2152-7806.163315455363626392919Open DOISearch in Google Scholar
Frakes JM, Figura NB, Ahmed KA, Juan TH, Patel N, Latifi K, et al. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases. J Neurosurg 2015; 123: 1261-7. doi: 10.3171/2014.12.JNS141919FrakesJMFiguraNBAhmedKAJuanTHPatelNLatifiKet alPotential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases20151231261710.3171/2014.12.JNS14191926140482Open DOISearch in Google Scholar
Hauswald H, Stenke A, Debus J, Combs SE. Linear accelerator-based stereotactic radiosurgery in 140 brain metastases from malignant melanoma. BMC Cancer 2015; 15: 537. doi: 10.1186/s12885-015-1517-1HauswaldHStenkeADebusJCombsSELinear accelerator-based stereotactic radiosurgery in 140 brain metastases from malignant melanoma20151553710.1186/s12885-015-1517-1451144626201853Open DOISearch in Google Scholar
Ivanov PI, Zubatkina IS, Tumarova DI, Andreev GI, Volkov NM. [Analysis of results of Gamma knife radiosurgery for patients with melanoma brain metastases]. [Russian]. Voprosy onkologii 2015; 61: 586-91. doi: УДК616.5-616-831-006;615.47.616-072.7IvanovPIZubatkinaISTumarovaDIAndreevGIVolkovNM[Analysis of results of Gamma knife radiosurgery for patients with melanoma brain metastases]20156158691УДК616.5-616-831-006;615.47.616-072.7Open DOISearch in Google Scholar
Ly D, Bagshaw HP, Anker CJ, Tward JD, Grossmann KF, Jensen RL, et al. Local control after stereotactic radiosurgery for brain metastases in patients with melanoma with and without BRAF mutation and treatment. J Neurosurg 2015; 123: 395-401. doi: 10.3171/2014.9.JNS141425LyDBagshawHPAnkerCJTwardJDGrossmannKFJensenRLet alLocal control after stereotactic radiosurgery for brain metastases in patients with melanoma with and without BRAF mutation and treatment201512339540110.3171/2014.9.JNS141425Open DOISearch in Google Scholar
Ostheimer C, Bormann C, Fiedler E, Marsch W, Vordermark D. Malignant melanoma brain metastases: treatment results and prognostic factors - a single-center retrospective study. Int J Oncol 2015; 46: 2439-48. doi: 10.3892/ijo.2015.2970OstheimerCBormannCFiedlerEMarschWVordermarkDMalignant melanoma brain metastases: treatment results and prognostic factors - a single-center retrospective study20154624394810.3892/ijo.2015.2970Open DOISearch in Google Scholar
Gallaher IS, Watanabe Y, DeFor TE, Dusenbery KE, Lee CK, Hunt MA, et al. BRAF mutation is associated with improved local control of melanoma brain metastases treated with Gamma knife radiosurgery. Front Oncol 2016; 6: 107. doi: 10.3389/fonc.2016.00107GallaherISWatanabeYDeForTEDusenberyKELeeCKHuntMAet alBRAF mutation is associated with improved local control of melanoma brain metastases treated with Gamma knife radiosurgery2016610710.3389/fonc.2016.00107Open DOISearch in Google Scholar
Patel BG, Ahmed KA, Johnstone PA, Yu HH, Etame AB. Initial experience with combined BRAF and MEK inhibition with stereotactic radiosurgery for BRAF mutant melanoma brain metastases. Melanoma Res 2016; 26: 382-6. doi: 10.1097/CMR.0000000000000250PatelBGAhmedKAJohnstonePAYuHHEtameABInitial experience with combined BRAF and MEK inhibition with stereotactic radiosurgery for BRAF mutant melanoma brain metastases201626382610.1097/CMR.0000000000000250Open DOISearch in Google Scholar
Rades D, Sehmisch L, Bajrovic A, Janssen S, Schild SE. Comparison of 20x2 Gy and 12x3 Gy for whole-brain irradiation of multiple brain metastases from malignant melanoma. In Vivo 2016; 30: 917-9. doi: 10.21873/in-vivo.11013RadesDSehmischLBajrovicAJanssenSSchildSEComparison of 20x2 Gy and 12x3 Gy for whole-brain irradiation of multiple brain metastases from malignant melanoma201630917910.21873/in-vivo.11013Open DOISearch in Google Scholar
Wolf A, Zia S, Verma R, Pavlick A, Wilson M, Golfinos JG, et al. Impact on overall survival of the combination of BRAF inhibitors and stereotactic radiosurgery in patients with melanoma brain metastases. J Neurooncol 2016; 127: 607-15. doi: 10.1007/s11060-016-2072-6WolfAZiaSVermaRPavlickAWilsonMGolfinosJGet alImpact on overall survival of the combination of BRAF inhibitors and stereotactic radiosurgery in patients with melanoma brain metastases20161276071510.1007/s11060-016-2072-6Open DOISearch in Google Scholar
Acharya S, Mahmood M, Mullen D, Yang D, Tsien CI, Huang J, et al. Distant intracranial failure in melanoma brain metastases treated with stereotactic radiosurgery in the era of immunotherapy and targeted agents. Adv Radiat Oncol 2017; 2: 572-80. doi: 10.1016/j.adro.2017.07.003AcharyaSMahmoodMMullenDYangDTsienCIHuangJet alDistant intracranial failure in melanoma brain metastases treated with stereotactic radiosurgery in the era of immunotherapy and targeted agents201725728010.1016/j.adro.2017.07.003570741929204524Open DOISearch in Google Scholar
All S, Patel H, Keller A, Ramakrishna NR. Initial volumetric response and local control following stereotactic radiosurgery for melanoma brain metastases. Int J Radiat Oncol Biol Phys 2017; 99 (2 Suppl 1): E62-3. doi: 10.1016/j.ijrobp.2017.06.739AllSPatelHKellerARamakrishnaNRInitial volumetric response and local control following stereotactic radiosurgery for melanoma brain metastases2017992 Suppl 1E62310.1016/j.ijrobp.2017.06.739Open DOISearch in Google Scholar
Feng R, Oermann EK, Shrivastava R, Gold A, Collins BT, Kondziolka D, et al. Stereotactic radiosurgery for melanoma brain metastases: a comprehensive clinical case series. World Neurosurg 2017; 100: 297-304. doi: 10.1016/j.wneu.2017.01.014FengROermannEKShrivastavaRGoldACollinsBTKondziolkaDet alStereotactic radiosurgery for melanoma brain metastases: a comprehensive clinical case series201710029730410.1016/j.wneu.2017.01.01428093345Open DOISearch in Google Scholar
Kaidar-Person O, Zagar TM, Deal A, Moschos SJ, Ewend MG, Sasaki-Adams D, et al. The incidence of radiation necrosis following stereotactic radiotherapy for melanoma brain metastases: the potential impact of immunotherapy. Anticancer Drugs 2017; 28: 669-75. doi: 10.1097/CAD.0000000000000497Kaidar-PersonOZagarTMDealAMoschosSJEwendMGSasaki-AdamsDet alThe incidence of radiation necrosis following stereotactic radiotherapy for melanoma brain metastases: the potential impact of immunotherapy2017286697510.1097/CAD.000000000000049728368903Open DOISearch in Google Scholar
Minniti G, Paolini S, D’Andrea G, Lanzetta G, Cicone F, Confaloni V, et al. Outcomes of postoperative stereotactic radiosurgery to the resection cavity versus stereotactic radiosurgery alone for melanoma brain metastases. J Neurooncol 2017; 132: 455-62. doi: 10.1007/s11060-017-2394-zMinnitiGPaoliniSD’AndreaGLanzettaGCiconeFConfaloniVet alOutcomes of postoperative stereotactic radiosurgery to the resection cavity versus stereotactic radiosurgery alone for melanoma brain metastases20171324556210.1007/s11060-017-2394-z28260130Open DOISearch in Google Scholar
Patel KR, Shoukat S, Oliver DE, Chowdhary M, Rizzo M, Lawson DH, et al. Ipilimumab and stereotactic radiosurgery versus stereotactic radiosurgery alone for newly diagnosed melanoma brain metastases. Am J Clin Oncol 2017; 40: 444-50. doi: 10.1097/COC.0000000000000199PatelKRShoukatSOliverDEChowdharyMRizzoMLawsonDHet alIpilimumab and stereotactic radiosurgery versus stereotactic radiosurgery alone for newly diagnosed melanoma brain metastases2017404445010.1097/COC.000000000000019926017484Open DOISearch in Google Scholar
Pessina F, Navarria P, Tomatis S, Cozzi L, Franzese C, Di Guardo L, et al. Outcome evaluation of patients with limited brain metastasis from malignant melanoma, treated with surgery, radiation therapy, and targeted therapy. World Neurosurg 2017; 105: 184-90. doi: 10.1016/j.wneu.2017.05.131PessinaFNavarriaPTomatisSCozziLFranzeseCDiGuardo Let alOutcome evaluation of patients with limited brain metastasis from malignant melanoma, treated with surgery, radiation therapy, and targeted therapy20171051849010.1016/j.wneu.2017.05.13128578123Open DOISearch in Google Scholar
Sperduto PW, Jiang W, Brown PD, Braunstein S, Sneed P, Wattson DA, et al. The prognostic value of BRAF, C-KIT, and NRAS mutations in melanoma patients with brain metastases. Int J Radiat Oncol Biol Phys 2017; 98: 1069-77. doi: 10.1016/j.ijrobp.2017.03.030SperdutoPWJiangWBrownPDBraunsteinSSneedPWattsonDAet alThe prognostic value of BRAF, C-KIT, and NRAS mutations in melanoma patients with brain metastases20179810697710.1016/j.ijrobp.2017.03.030692553128721890Open DOISearch in Google Scholar
Xu Z, Lee CC, Ramesh A, Mueller AC, Schlesinger D, Cohen-Inbar O, et al. BRAF V600E mutation and BRAF kinase inhibitors in conjunction with stereotactic radiosurgery for intracranial melanoma metastases. J Neurosurg 2017; 126: 726-34. doi: 10.3171/2016.2.JNS1633XuZLeeCCRameshAMuellerACSchlesingerDCohen-InbarOet alBRAF V600E mutation and BRAF kinase inhibitors in conjunction with stereotactic radiosurgery for intracranial melanoma metastases20171267263410.3171/2016.2.JNS163327203149Open DOISearch in Google Scholar
Diao K, Bian SX, Routman DM, Yu C, Kim PE, Wagle NA, et al. Combination ipilimumab and radiosurgery for brain metastases: tumor, edema, and adverse radiation effects. J Neurosurg 2018; 129: 1397-406. doi: 10.3171/2017.7.JNS171286DiaoKBianSXRoutmanDMYuCKimPEWagleNAet alCombination ipilimumab and radiosurgery for brain metastases: tumor, edema, and adverse radiation effects2018129139740610.3171/2017.7.JNS171286746998229303446Open DOISearch in Google Scholar
Diao K, Bian SX, Routman DM, Yu C, Ye JC, Wagle NA, et al. Stereotactic radiosurgery and ipilimumab for patients with melanoma brain metastases: clinical outcomes and toxicity. J Neurooncol 2018; 139: 421-9. doi: 10.1007/s11060-018-2880-yDiaoKBianSXRoutmanDMYuCYeJCWagleNAet alStereotactic radiosurgery and ipilimumab for patients with melanoma brain metastases: clinical outcomes and toxicity2018139421910.1007/s11060-018-2880-y746998129696531Open DOISearch in Google Scholar
Fang P, Boehling NS, Koay EJ, Bucheit AD, Jakob JA, Settle SH, et al. Melanoma brain metastases harboring BRAF V600K or NRAS mutations are associated with an increased local failure rate following conventional therapy. J Neurooncol 2018; 137: 67-75. doi: 10.1007/s11060-017-2695-2FangPBoehlingNSKoayEJBucheitADJakobJASettleSHet alMelanoma brain metastases harboring BRAF V600K or NRAS mutations are associated with an increased local failure rate following conventional therapy2018137677510.1007/s11060-017-2695-229198052Open DOISearch in Google Scholar
Gabani P, Fischer-Valuck BW, Johanns TM, Hernandez-Aya LF, Keller JW, Rich KM, et al. Stereotactic radiosurgery and immunotherapy in melanoma brain metastases: patterns of care and treatment outcomes. Radiother Oncol 2018; 128: 266-73. doi: 10.1016/j.radonc.2018.06.017GabaniPFischer-ValuckBWJohannsTMHernandez-AyaLFKellerJWRichKMet alStereotactic radiosurgery and immunotherapy in melanoma brain metastases: patterns of care and treatment outcomes20181282667310.1016/j.radonc.2018.06.01729960685Open DOISearch in Google Scholar
Kano H, Morales-Restrepo A, Iyer A, Weiner GM, Mousavi SH, Kirkwood JM, et al. Comparison of prognostic indices in patients who undergo melanoma brain metastasis radiosurgery. J Neurosurg 2018; 128: 14-22. doi: 10.3171/2016.9.JNS161011KanoHMorales-RestrepoAIyerAWeinerGMMousaviSHKirkwoodJMet alComparison of prognostic indices in patients who undergo melanoma brain metastasis radiosurgery2018128142210.3171/2016.9.JNS16101128106495Open DOISearch in Google Scholar
Kotecha R, Miller JA, Venur VA, Mohammadi AM, Chao ST, Suh JH, et al. Melanoma brain metastasis: the impact of stereotactic radiosurgery, BRAF mutational status, and targeted and/or immune-based therapies on treatment outcome. J Neurosurg 2018; 129: 50-9. doi: 10.3171/2017.1.JNS162797KotechaRMillerJAVenurVAMohammadiAMChaoSTSuhJHet alMelanoma brain metastasis: the impact of stereotactic radiosurgery, BRAF mutational status, and targeted and/or immune-based therapies on treatment outcome201812950910.3171/2017.1.JNS16279728799876Open DOISearch in Google Scholar
Ladwa R, Atkinson V. The changing paradigm of management in melanoma brain metastases. Asia Pac J Clin Oncol 2018; 14: 453-8. doi: 10.1111/ajco.12998LadwaRAtkinsonVThe changing paradigm of management in melanoma brain metastases201814453810.1111/ajco.1299829932306Open DOISearch in Google Scholar
Matsunaga S, Shuto T, Yamamoto M, Yomo S, Kondoh T, Kobayashi T, et al. Gamma Knife radiosurgery for metastatic brain tumors from malignant melanomas: a Japanese multi-institutional cooperative and retrospective cohort study (JLGK1501). Stereotac Funct Neurosurg 2018; 96: 162-71. doi: 10.1159/000489948MatsunagaSShutoTYamamotoMYomoSKondohTKobayashiTet alGamma Knife radiosurgery for metastatic brain tumors from malignant melanomas: a Japanese multi-institutional cooperative and retrospective cohort study (JLGK1501)2018961627110.1159/00048994829969770Open DOISearch in Google Scholar
Tio M, Wang X, Carlino MS, Shivalingam B, Fogarty GB, Guminski AD, et al. Survival and prognostic factors for patients with melanoma brain metastases in the era of modern systemic therapy. Pigment Cell Melanoma Res 2018; 31: 509-15. doi: 10.1111/pcmr.12682TioMWangXCarlinoMSShivalingamBFogartyGBGuminskiADet alSurvival and prognostic factors for patients with melanoma brain metastases in the era of modern systemic therapy2018315091510.1111/pcmr.1268229277979Open DOISearch in Google Scholar
Zubatkina I, Ivanov P. Early imaging radioresponsiveness of melanoma brain metastases as a predictor of patient prognosis. J Neurosurg 2018; 129: 354-65. doi: 10.3171/2017.1.JNS162075ZubatkinaIIvanovPEarly imaging radioresponsiveness of melanoma brain metastases as a predictor of patient prognosis20181293546510.3171/2017.1.JNS16207528841116Open DOISearch in Google Scholar
Jardim A, Scott J, Drew Z, Foote MC, Sadasivan AP, Hall B, et al. Extent of surrounding edema does not correlate with acute complications after radiosurgery for melanoma brain metastases. Neurooncol 2019; 145: 581-5. doi: 10.1007/s11060-019-03330-9JardimAScottJDrewZFooteMCSadasivanAPHallBet alExtent of surrounding edema does not correlate with acute complications after radiosurgery for melanoma brain metastases2019145581510.1007/s11060-019-03330-931691060Open DOISearch in Google Scholar
Mastorakos P, Xu Z, Yu J, Hess J, Qian J, Chatrath A, et al. BRAF V600 mutation and BRAF kinase inhibitors in conjunction with Stereotactic radiosurgery for intracranial melanoma metastases: a multicenter retrospective study. Neurosurgery 2019; 84: 868-80. doi: 10.1093/neuros/nyy203MastorakosPXuZYuJHessJQianJChatrathAet alBRAF V600 mutation and BRAF kinase inhibitors in conjunction with Stereotactic radiosurgery for intracranial melanoma metastases: a multicenter retrospective study2019848688010.1093/neuros/nyy203650544329846702Open DOISearch in Google Scholar
Tjong MC, Moraes FY, Shultz D. Intracranial control and radionecrosis in melanoma patients with brain metastases treated with stereotactic radiosurgery. Radiother Oncol 2019; 139(Suppl 1): S59-60. doi: 10.1016/S0167-8140%2819%2933190-1TjongMCMoraesFYShultzDIntracranial control and radionecrosis in melanoma patients with brain metastases treated with stereotactic radiosurgery2019139Suppl 1S596010.1016/S0167-8140%2819%2933190-1Open DOISearch in Google Scholar
McHugh FA, Kow CY, Falkov A, Heppner P, Law A, Bok A, et al. Metastatic melanoma: surgical treatment of brain metastases - Analysis of 110 patients. J Clin Neurosci 2020; 73: 144-9. doi: 10.1016/j.jocn.2019.12.063McHughFAKowCYFalkovAHeppnerPLawABokAet alMetastatic melanoma: surgical treatment of brain metastases - Analysis of 110 patients202073144910.1016/j.jocn.2019.12.06331956087Open DOISearch in Google Scholar
Pomeranz Krummel DA, Nasti TH, Izar B, Press RH, Xu M, Lowder L, et al. Impact of sequencing radiation therapy and immune checkpoint inhibitors in the treatment of melanoma brain metastases. Int J Radiat Oncol Biol Phys 2020; 108: 157-63. doi: 10.1016/j.ijrobp.2020.01.043PomeranzKrummel DANastiTHIzarBPressRHXuMLowderLet alImpact of sequencing radiation therapy and immune checkpoint inhibitors in the treatment of melanoma brain metastases20201081576310.1016/j.ijrobp.2020.01.043783906032057994Open DOISearch in Google Scholar